Q2 2020 EPS Estimates for Prestige Consumer Healthcare Inc Lowered by Jefferies Financial Group (NYSE:PBH)

Q2 2020 EPS Estimates for Prestige Consumer Healthcare Inc Lowered by Jefferies Financial Group (NYSE:PBH)

July 17, 2019 Off By administrator

Prestige Consumer Healthcare Inc (NYSE:PBH) – Research analysts at Jefferies Financial Group dropped their Q2 2020 earnings per share (EPS) estimates for shares of Prestige Consumer Healthcare in a research note issued to investors on Tuesday, June 25th, Zacks Investment Research reports. Jefferies Financial Group analyst S. Wissink now expects that the company will post earnings of $0.62 per share for the quarter, down from their prior forecast of $0.64. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q4 2020 earnings at $0.77 EPS, FY2020 earnings at $2.82 EPS, Q1 2021 earnings at $0.67 EPS, Q3 2021 earnings at $0.79 EPS, Q4 2021 earnings at $0.78 EPS and FY2021 earnings at $2.89 EPS.

PBH has been the topic of a number of other research reports. Zacks Investment Research downgraded Hanger from a “hold” rating to a “sell” rating in a report on Tuesday, May 28th. CIBC restated a “hold” rating and issued a $84.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday, May 27th. Royal Bank of Canada restated a “buy” rating and issued a $97.00 price objective on shares of Prestige Consumer Healthcare in a report on Friday, March 15th. ValuEngine downgraded Intersect ENT from a “buy” rating to a “hold” rating in a report on Monday. Finally, TheStreet downgraded USD Partners from a “b-” rating to a “c+” rating in a report on Friday, May 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $57.77.

Shares of PBH opened at $30.97 on Thursday. The firm has a market cap of $1.62 billion, a P/E ratio of 11.14, a price-to-earnings-growth ratio of 1.80 and a beta of 0.93. Prestige Consumer Healthcare has a fifty-two week low of $26.25 and a fifty-two week high of $41.76. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The firm has a 50-day simple moving average of $30.65.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.02. The company had revenue of $241.03 million for the quarter, compared to the consensus estimate of $237.22 million. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.67%. The firm’s quarterly revenue was down 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.62 EPS.

Large investors have recently added to or reduced their stakes in the stock. Primecap Management Co. CA increased its stake in shares of Prestige Consumer Healthcare by 51.6% in the first quarter. Primecap Management Co. CA now owns 42,600…

(Excerpt) To read the full article , click here
Image credit: source